Header Logo

Connection

RICHARD BOND to Immunotherapy, Adoptive

Back to Details
This is a "connection" page, showing publications RICHARD BOND has written about Immunotherapy, Adoptive.
RICHARD BOND
Connection Strength
0.090
Immunotherapy, Adoptive
  1. Systemic ?-Adrenergic Receptor Activation Augments the ex vivo Expansion and Anti-Tumor Activity of V?9Vd2 T-Cells. Front Immunol. 2019; 10:3082.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.